FORMULATION, OPTIMIZATIONANDEVALUATION OF SUBLINGUAL FILM OF ENALAPRILMALEATE USING 32 FULL FACTORIAL DESIGN

SATYAJIT SAHOO; KIRTI MALVIYA; AMI MAKWANA; PRASANTA KUMAR MOHAPATRA; ASITRANJAN SAHU

doi:10.22159/ijap.2021v13i1.39446

Authors

SATYAJIT SAHOO C.U. Shah College of Pharmacy and Research, Wadhwan,Surendranagar, Gujarat, India
KIRTI MALVIYA C.U. Shah College of Pharmacy and Research, Wadhwan,Surendranagar, Gujarat, India
AMI MAKWANA C.U. Shah College of Pharmacy and Research, Wadhwan,Surendranagar, Gujarat, India
PRASANTA KUMAR MOHAPATRA C.U. Shah College of Pharmacy and Research, Wadhwan,Surendranagar, Gujarat, India
ASITRANJAN SAHU C.U. Shah College of Pharmacy and Research, Wadhwan,Surendranagar, Gujarat, India

DOI:

https://doi.org/10.22159/ijap.2021v13i1.39446

Keywords:

Sublingual film, Hypertension, Enalaprilmaleate, HPMC E 15, Polyethylene glycol, 32 full factorial designs

Abstract

Objective: The purpose of this investigation was to formulate, optimize and evaluate sublingual film of Enalapril maleate for rapid management of Hypertension.

Methods: Sublingual films were prepared by solvent casting method. Present investigation were formulated by using HPMC E 15 (X₁) as polymer and Polyethylene glycol (X₂) as plasticizer were chosen as independent variables in 3² full factorial design while Tensile strength (TS), Disintegration time (DT) and % Cumulative drug release at 10 min. (% CDR) were taken as dependent variables. The various physical parameters were evaluated for sublingual films such as thickness, tensile strength, folding endurance, disintegration time, surface pH and % CDR.

Results: From the experimental study, it was concluded that the optimized batch F₈ showed 98.6 %, the highest release of the drug. Stability study was performed by taking an optimized formulation and it was observed stable. The sublingual films showed acceptable results in all studies such as thickness, tensile strength, folding endurance, disintegration time, surface pH and % CDR at 10 min. R² values for Tensile Strength (Y₁), Disintegration time (Y₂) and % cumulative drug release at 10 min. of Enalaprilmaleate(Y₃) found to be 0.9852, 0.9829 and 0.9641 respectively. Thus, a good correlation between dependent and independent variables was developed.

Conclusion: 3² full factorial design was successfully applied during preparation, optimization and evaluation of sublingual films of Enalapril maleate. The present investigation showed quick disintegration and fast release of the drug for rapid management of Hypertension.

Downloads

Download data is not yet available.

References

Dixit RP, PuthliSP. Oral strip technology: overview and future potentia. J Controlled Release 2009;139:94-107.

Panda BP, Dey NS, RaoMEB. Development of innovative orally fast disintegrating film dosage forms: a review. Int J Pharm SciNanotechnol2012;5:1666-78.

AryaArun,ChandraAmrish. Fast dissolving oral films. An innovation drug delivery system and dosage form.Int J Chem Tech Res 2010;2:576-83.

MohapatraPrasanta Kumar, Pratibha, TomerVivek, Gupta Mandeep Kumar, SahooSatyajit. Design and development of losartan potassium floating drug delivery systems. Int J Appl Pharm 2018;10:168-73.

Patel V, Patel F, Liu F, Brown M. Advance in oral transmucosal drug delivery. J Controlled Release 2011;153:106-16.

Madhav S, Shakya A, Shakya P, Singh K. Orotransmucosal drug delivery system: areview. J Controlled Release 2009;140:2-11.

PatelKN,PancholiSS. Sublingual route for systemic drug delivery:apharmaceuiticalreview. Int J Res Pharm Biomed Sci2012;3:913-23.

ArunArya, AmrishChandra. Fast dissolving oral films. An innovation drug delivery system and dosage form”.Int J Chem Tech Res2010;2:576-83.

NarangNeha, Sharma Jyoti. Sublingual mucosa as a route for systemic drug delivery.Int J Pharm PharmSci 2011;3:18-22.

SahooSatyajit,Makwana Ami, SahuAsitRanjan, KeshriAsha, Dash Vikash. Formulation and evaluation of sublingual film of asenapine maleate by using 32full factorial design. Aegaeum 2020;8:80-94.

Marina Koland, VP Sandeep. The design and characterization of sublingual films of ondansetron hydrochloride.Int J ChemSci 2009;7:2927-38.

SahooSatyajit, Bhatt JJ, Oza NA, Sahu AR, Patel LD. Formulation development and optimization of mouth dissolving film containing escitalopram oxalate using 32Full factorial design.Inventi Rapid: Pharm Tech 2015;4:1-7.

WetzelsGE, NelemansP, Schouten JS. Facts and fiction of poor compliance as a cause of inadequate blood pressure control: a systematic review. J Hypertension 2004;22:1849-55.

Kale Sunil, PatilAmeeta,RHMandlecha. Compliance and adverse drug effects of antihypertensive in rural India. J ClinDiagnostic Res 2011;5:775-9.

Naomi DL, Fisher MD,Gregory Curfman. Hypertension-a public health challenge of global proportions. JAMA2018;320:1757-9.

Carlson E, Chandler W, Galdo I, Kudla T. Automated integrated forced degradation and drug excipients compatibility studies. J Assoc Lab Autom 2005;10:374-80.

Arya A, Chandra A, Sharma V, Pathak K. Fast dissolving oral film: an innovation drug delivery system and dosage form.Int J Chem Tech Res 2010;2:576-83.

Yellanki SK, Jagtap S, Masareddy R. Dissofilm: a novel approach fordelivery of phenobarbital; design and characrization. J Young Pharm 2013;1:181-8.

Kalyan S, Bansal M. Recent trends in the development of oral dissolving film. Int JPharma Tech Res 2012;4:725-33.

JuluruN. Fast dissolving oral films: a review.Int J Adv Pharm BiolChem 2013;2:108-12.

Ciluzzo F, Cupone I, Minghetti P, Buratti S, Gennari C, MontanariL. Diclofenac fast-dissolving film: suppression of bitterness by a taste-sensing system. Drug Dev Industrial Pharm 2011;37:252-9.

Chauhan S, Lin S, Madan P. Preparation and evaluation of Nicotin hydrogen tartrate fast dissolving filmsfor smoking cessation. Asian J Pharm Sci 2012;7:181-92.

M Koland, VP Sandeep, NR Charyulu. Fast dissolving sublingual films of ondansetron hydrochloride: effect of additives on in vitro drug release and mucosal permeation. J Young Pharm 2010;2:216-22.

NLPrasanthi, C Sowmya. Design and development of sublingual fast dissolving film for an antiasthmatic drug. Scholars Research Library 2012;3:382-95.

Guideline ICH. Stability testing guidelines: stability testing of new drug substances and products. ICH Q1A (R2) (CPMP/ICH/2736/99); 1999.

Pavia DL, Lampman GM, Kriz GS, Vyvyan JR. Introduction to spectroscopy. 5thed. CengageLearning India Pvt. Ltd., India; 2015. p. 37-8.

Ferreira SC, Bruns RE, Ferreira HS, Matos GD, David JM, Brandao GC. Box-behnkendesign: an alternative for the optimization of analytical methods. Anal ChimActa 2007;597:179-86.

Bolton S. Optimization techniques in pharmaceutical statistics. Practical and clinical applications. 3rded. New York: Marcel Dekker; 1997.

DeoghareHarshada,AhirePrajakta, YadavGhanashyam, MaruAvish. Formulation and evaluation of fast dissolving films of enalapril maleate. World J Pharm Res2016;5:1751-9.

Irene Thomas, BinuAnand, Beena P, Elessy Abraham. Formulation and evaluation of fast dissolving buccal film of Enalapril maleate. J Pharm SciInnov 2017;6:115-9.